June 18, 2020
New Report Highlights Urgent Need for Improved Treatments for Children with MDR-TB
Tuberculosis is a leading cause of death worldwide. Children with drug-resistant TB need improved treatment options June 5, 2020
Standing Against Racism and Injustice
A Message to the TB Alliance Family June 2, 2020
InveniAI Announces Strategic Partnership with TB Alliance to Advance the Development of Transformative Therapies for Tuberculosis
TB Alliance to leverage AlphaMeld, an AI-powered platform to capture and accelerate innovation to address unmet needs May 28, 2020
TB Alliance Commercialization Partner, Mylan, Launches Named Patient Access Program for New Highly Resistant TB Treatment
The NPAP is designed for patients in countries where regulatory approval or other access mechanisms are not yet available April 21, 2020
A Conversation with Mitchell Warren
How the TB Alliance Stakeholders Association Will Help Realize the Promise of New Therapies March 24, 2020
COVID-19: a message of solidarity on World TB Day 2020
February 12, 2020
TB Alliance Names Dr. Daniel Everitt Vice President and Chief Medical Officer
Dr. Everitt to lead development planning of novel drug regimens to treat tuberculosis February 3, 2020